Abstract:Multiple sclerosis is an autoimmune disease characterized by demyelination and axonal damage in the central nervous system. Plasmacytoid dendritic cell (pDC), due to its unique roles in antiviral immunity and immune regulation, has become the focus of multiple sclerosis research. This article systematically reviews the biological characteristics and immunological functions of the plasmacytoid dendritic cell (pDC), focusing on its recruitment to the central nervous system in multiple sclerosis, changes in functional subtypes, and maturational defects. At the same time, it summarizes the effects of various current clinical multiple sclerosis treatment drugs on pDC functions. Through a deeper understanding of the mechanism of action of pDC, new ideas are provided for revealing the pathogenesis of multiple sclerosis and developing novel targeted therapeutic strategies.